Launched as Google Ventures in 2009, GV is the venture capital arm of Alphabet, Inc. We’ve invested in more than 300 companies that push the edge of what’s possible. In the fields of life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture, our companies aim to improve lives and change industries.


We’ve built a team of world-class engineers, designers, physicians, scientists, marketers, and investors who work together to provide these startups exceptional support on the road to success. We help our companies interface with Google, providing unique access to the world’s best technology and talent.

Type
Investor
HQ
Mountain View, US
Founded
2009
Website
gv.com
GV was founded in 2009 and is headquartered in Mountain View, US

Key People/Management at GV

David Krane

David Krane

CEO & Managing Partner
Graham Spencer

Graham Spencer

Managing Partner
Jonathan Faerber

Jonathan Faerber

Chief Financial Officer
Krishna Yeshwant

Krishna Yeshwant

General Partner
Adam Ghobarah

Adam Ghobarah

General Partner
Blake Byers

Blake Byers

General Partner
Rick Klau

Rick Klau

Partner
Deena Shakir

Deena Shakir

Partner
Tracie Rotter

Tracie Rotter

Partner
Vineeta Agarwala

Vineeta Agarwala

Venture Partner
Scott Davis

Scott Davis

Venture Partner
Ben Robbins

Ben Robbins

Venture Partner
Anthony Philippakis

Anthony Philippakis

Venture Partner
Daphne Chang

Daphne Chang

General Counsel
Erik Nordlander

Erik Nordlander

Engineering Partner
Barkha Gvalani

Barkha Gvalani

Principal
Choongsoon Bae

Choongsoon Bae

Engineering Partner
Kristen Brillantes

Kristen Brillantes

Design Producer

GV Office Locations

GV has an office in Mountain View
Mountain View, US (HQ)
Google Bldg 1489 1489 Charleston Rd
Show all (1)

GV Investment Portfolio

Stage Distribution

Top Sectors Distribution

Round Size Distribution

GV News and Updates

Newsrooms Eye Smart Cloud Processing

New capabilities accelerate ‘speed to air’

GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech

 Leaning on its in-house life sciences expertise GV has backed another biotech startup in the UK, co-leading a £20 million ($27.1M) Series A in Oxford University spinout Vaccitech, which is developing a universal flu vaccine. Read More

Quartet raises $40 million to bridge the physical and mental health care divide

Quartet, a technology platform that serves to bridge the gap between primary care and mental health providers, has raised $40 million in a series C round of funding led by F-Prime Capital Partners and Polaris Partners, with participation from existing investors including GV (Google Ventures) and Oak…

DNAnexus nets $58 mln

DNAnexus Inc, a provider of biomedical informatics and data management, has raised $58 million in financing. Foresite Capital led the round with participation from Microsoft, GV, TPG Biotech, WuXi NextCODE, Claremont Creek Ventures and MidCap Financial.

'Best of GV Expo 2017' eBook Now Available

The 2017 GV Expo covered topics like virtual reality, audiovisual archiving, the military’s use of social media and more.

X Marks the Spot for New Grass Valley K-Frame

Fluidity may best describe where those involved with video production find themselves today, and Grass Valley intends to help those involved with live TV deal with the unfolding changes in formats, signal sources and resolutions.
Show more

GV's Web-traffic and Trends

GV Company Life and Culture